Sasha Austin

Comptroller/Controller/Auditor chez OLEMA PHARMACEUTICALS, INC.

Fortune : 213 520 $ au 31/05/2026

Commercial Services

Consumer Services

Health Technology

Profil

Sasha Austin currently works at The American Institute of Certified Public Accountants, as Member and Olema Pharmaceuticals, Inc., as Vice President-Finance & Controller from 2023.
Ms. Austin also formerly worked at GigCapital Global, as Controller from 2020 to 2021.
Ms. Austin received her undergraduate degree from Seattle University.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
OLEMA PHARMACEUTICALS, INC. 0,02 %	02/02/2026	16 188 ( 0,02 % )	213 520 $	31/05/2026

Postes actifs de Sasha Austin

Sociétés	Poste	Début
OLEMA PHARMACEUTICALS, INC.	Comptroller/Controller/Auditor	01/04/2023
The American Institute of Certified Public Accountants The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants	Corporate Officer/Principal	-

Tous les postes actifs de Sasha Austin

Anciens postes connus de Sasha Austin

Sociétés	Poste	Fin

Voir l'expérience en détail de Sasha Austin

Formation de Sasha Austin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Sasha Austin

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	3
The American Institute of Certified Public Accountants The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants	Commercial Services
Seattle University Seattle University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Olema Pharmaceuticals, Inc. Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer	Health Technology